Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveJPM raises Option Care Health price target to $33

Live News EQUITY FLASH L impact Oct 07, 2026, 07:01 PM UTC

JPM raises Option Care Health price target to $33

Benzinga reports JPM set a $33 price target for Option Care Health.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

JPM OPCH

Related stories

Newmont Reports Third-Quarter Revenue of $6.36B, EPS of $2.35 Revenue rose 15.2% year over year to $6.36 billion, while net income attributable to Newmont stockholders increased 35.1% to $2.48 billion. Diluted EPS rose 40.7% to $2.35 as highe M impact | EQUITY | Oct 22, 2026, 09:01 PM UTC Robert Half Q3 2026 Earnings Call Begins Robert Half’s quarterly earnings call has begun. M impact | EQUITY | Oct 22, 2026, 08:57 PM UTC Centrus Schedules Quarterly Earnings Call for November 5 Centrus will release its third-quarter earnings report and hold a conference call on November 5, 2026, at 8:30 a.m. ET. M impact | EQUITY | Oct 22, 2026, 08:56 PM UTC RingCentral Q3 Revenue Rises 5.9%, Raises 2026 Outlook RingCentral reported third-quarter 2026 revenue of $676 million, up 5.9% year over year. Non-GAAP operating margin was 24.7%; non-GAAP diluted EPS was $1.33 and GAAP diluted EPS wa M impact | EQUITY | Oct 22, 2026, 08:53 PM UTC CBRE Reports Third-Quarter 2026 Revenue of $11.52 Billion CBRE reported revenue of $11.52 billion, up 12.7% year over year, and net income attributable to the company of $443 million, up 22%. Advisory Services and Building Operations and M impact | EQUITY | Oct 22, 2026, 08:51 PM UTC Gilead to Acquire PepStar Oral IL-23R Program for $1.275 Billion Gilead agreed to acquire the program from privately held PepStar Therapeutics for $1.275 billion in cash, gaining worldwide rights to its lead asset, HCXT-2001. M impact | EQUITY | Oct 22, 2026, 08:50 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.